Extended warranty and preventative maintenance for imagexpress micro confocal

Ended Purchase Order Awarded Last action

Contract number
75N95020P00095
Awardee
Awarding agency
Obligated
$47,705

Award facts

Opportunity
Contract value 20% obligated
  • $47,705.00 Current, with exercised options
  • $243,974.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
811219 Other Electronic and Precision Equipment Repair and Maintenance
PSC
J074 Maint/Repair/Rebuild Of Equipment- Office Machines/Text Processing Sys/Visible Record Equipment
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Jose, CA 95134, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract, valued at $243,974.00, is for extended warranty and preventative maintenance services on an existing ImageXpress Micro Confocal instrument used by NCATS for high-throughput microplate-based automated imaging of cellular-level biological activities. The original solicitation was a combined synopsis/solicitation that sought an annual maintenance agreement from the original equipment manufacturer to support NCATS' existing imaging system. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75N95020P00095?

75N95020P00095 was awarded to Molecular Devices LLC by National Institute on Drug Abuse (National Institutes of Health) on February 21, 2020.

How much is contract 75N95020P00095 worth?

The government has obligated $47,705 on 75N95020P00095. Its potential value, with all options, is $243,974.

Which agency awarded contract 75N95020P00095?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00095, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95020P00095 competed?

The extent of competition for 75N95020P00095 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award